CMS Open Payments · Program Year 2024
Varex Imaging Corporation
Varex Imaging Corporation reported $1,023,635.26 across General Payments, Research, and Ownership to 68 physicians and teaching hospitals across 69 transactions.
- $1.0M Above-median payer
- All-tracks total
- 69 Below-median volume
- Transactions
- 68 Below-median reach
- Recipients
- +$303.52
- General Payments vs PY2023
Varex Imaging Corporation reported $1,023,635.26 across all CMS Open Payments tracks (General + Research + Ownership) to 68 physicians and teaching hospitals in Program Year 2024 - ranking #618 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $102,341.43, averaging $15.1K per recipient.
How Varex Imaging Corporation's $1.0M all-tracks total breaks down
Varex Imaging Corporation's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
22/100
Total payments
F
19/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer varex-imaging-corporation Varex Imaging Corporation
$1.0M · #618/1,925 · 0.0% industry · PY2024
- TOT $1.0M
- RANK #618
- SHARE 0.0%
- TXN 69
- RCP 68
- CAT 4
- GEN $102.3K
- ΔGEN +$303.52
- TOP1 97.6%
- PY 2024
Volume peers
Nearest volume peer: Choice Spine, LLC ($1.0M)
Varex Imaging Corporation sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Varex Imaging Corporation's CMS-reported General Payments increased by $303.52 (+0.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: VAREX IMAGING CORPORATIONPY2023: VAREX IMAGING CORPORATIONPY2024: Varex Imaging Corporation. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $102,037.91
- PY2024
- $102,341.43
What the Data Shows for Varex Imaging Corporation
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Varex Imaging Corporation, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 4 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $89.8K across 4 transactions, 87.7% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Varex Imaging Corporation made 4 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $89.8K, 87.7% of General Payments.
Varex Imaging Corporation reports 4 general-payment categories - the top three are Compensation for Services Other Than Consulting (87.7%), Travel and Lodging (8.2%), and Consulting Fee (2.4%). The remaining 1 category make up 1.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Varex Imaging Corporation divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $89.8K | 4 | 87.7% |
| Travel and Lodging | $8.4K | 36 | 8.2% |
| Consulting Fee | $2.5K | 1 | 2.4% |
| Food and Beverage | $1.7K | 27 | 1.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $102,341.43 (100.0%) of $102,341.43 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Varex Imaging Corporation
The five named recipients with the highest reported General Payments from this company
- 1
Jocelyn D Chertoff
$99,841.43 across 67 reported transactions
- 2
Sherwin Pollock
$2,500.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Varex Imaging Corporation ranks #618 of 1,925 by total payments (top 32% by spend) but is notably more concentrated than that alone would suggest -- #153 of 1,838 by HHI (top 8% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Clinical Technology, Inc : $36.5K total payments, HHI 9705
- BrainScope Company, Inc. : $95.9K total payments, HHI 9696
- Cardinal Health Inc : $62.6K total payments, HHI 9636
- Mycovia Pharmaceuticals, Inc. : $7.4K total payments, HHI 9587
- Purdue Pharma L.P. : $1.9M total payments, HHI 9551
- Revvity, Inc. : $6.6K total payments, HHI 9549
- Varex Imaging Corporation (this company) : $102.3K total payments, HHI 9523
- Henry Schein, Inc. : $27.4M total payments, HHI 9520
- Sonavex, Inc. : $61.8K total payments, HHI 9490
- Fujirebio Diagnostics, Incorporated : $2.1M total payments, HHI 9489
- Sensible Medical Innovations Inc : $37.1K total payments, HHI 9459
- Biolife, L.L.C. : $7.9K total payments, HHI 9454
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Varex Imaging Corporation's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Varex Imaging Corporation.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Varex Imaging Corporation.
Showing 6 of 1,924 companies with CMS-reported payment data.
PENTAX of America, Inc.
Qiagen, LLC
iotaMotion, Inc.
Bristol Myers Squibb Company
Radius Health, Inc.
Put this to use
Varex Imaging Corporation ranks #618 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Varex Imaging Corporation sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Varex Imaging Corporation. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.